🇺🇸 FDA
Pipeline program

VX-950

VX05-950-102

Phase 2 small_molecule completed

Quick answer

VX-950 for Hepatitis C is a Phase 2 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 2 ClinicalTrials.gov record(s).

Program details

Company
VERTEX PHARMACEUTICALS INC / MA
Indication
Hepatitis C
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials